Fuhst et al., 2013 - Google Patents
Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposureFuhst et al., 2013
View PDF- Document ID
- 15043790520069515653
- Author
- Fuhst R
- Runge F
- Buschmann J
- Ernst H
- Praechter C
- Hansen T
- von Erichsen J
- Turowska A
- Hoymann H
- Müller M
- Pohlmann G
- Sewald K
- Ziemann C
- Schlüter G
- Garn H
- Publication year
- Publication venue
- Pulmonary pharmacology & therapeutics
External Links
Snippet
DNAzymes are single-stranded catalytic DNA molecules that bind and cleave specific sequences in a target mRNA molecule. Their potential as novel therapeutic agents has been demonstrated in a variety of disease models. However, no studies have yet addressed their …
- 108010091307 Catalytic DNA 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fuhst et al. | Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure | |
| Kim et al. | Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation | |
| Michaeloudes et al. | Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases | |
| Gielen et al. | Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons | |
| Hou et al. | NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy | |
| Du et al. | NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy | |
| Shao et al. | Increased lipocalin-2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion | |
| Sykes et al. | Rhinovirus 16–induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients | |
| Zeviani et al. | Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu (UUR) | |
| Sunil et al. | Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver | |
| Alzahrani et al. | Non-viral causes of liver cancer: does obesity led inflammation play a role? | |
| Kenyon et al. | Airway fibrosis in a mouse model of airway inflammation | |
| Onaolapo et al. | A histological study of the hepatic and renal effects of subchronic low dose oral monosodium glutamate in Swiss albino mice | |
| Pourgonabadi et al. | Saliva initiates the formation of pro-inflammatory macrophages in vitro | |
| Foldenauer et al. | Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection | |
| CN103211821A (en) | Drugs and uses | |
| CN101472579B (en) | Drugs and uses | |
| Garatachea et al. | Association of the K153R polymorphism in the myostatin gene and extreme longevity | |
| Nordskog et al. | Kinetic analysis of cytokine response to cigarette smoke condensate by human endothelial and monocytic cells | |
| US20220211762A1 (en) | Pharmaceutical composition for treating sepsis or systemic inflammatory response syndrome, comprising isolated mitochondria as active ingredient | |
| Meena et al. | Sub-acute toxicity of cultured mycelia of himalayan entomogenous fungus Cordyceps sinensis (Berk.) Sacc. In rats | |
| Schierwagen et al. | Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure | |
| Tigani et al. | Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats | |
| Cui et al. | A preliminary investigation of the toxic effects of Benzylpenicilloic acid | |
| Mian et al. | Cigarette smoke attenuation of poly I: C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-β production |